Lecithin in Parkinson’s Disease
Pathological and biochemical evidence reviewed favours the hypothesis that the dementia seen in Parkinson’s disease, particularly after long-term levodopa therapy, is akin to Alzheimer’s disease. We postulate, in late Parkinson’s disease, the development of a relative cholinergic deficiency due to the accelerated process of aging and the presence of neurofibrillary tangles (with choline acetyl transferase deficiency). This process would be enhanced by the imbalance in favour of dopaminergic predominance caused by chronic levodopa therapy, and would partially explain the increase in dementia. As a test of this hypothesis we have given 10 levodopa-treated parkinsonian patients with dementia, a regimen of lecithin (average 20 gms/day). A clear improvement in Kohs block design test of constructive ability was noted with a decrease in the toxic symptoms of confusion, hallucinations and nightmares. In another study lecithin produced a decrease in levodopa-induced abnormal movements, but at the expense of motor Performance. These preliminary investigations indicate that the progressive dementia of Parkinson’s disease may not be irreversible.
KeywordsLocus Coeruleus Neurofibrillary Tangle Dentate Nucleus Choline Chloride Cortical Atrophy
Unable to display preview. Download preview PDF.
- Barbeau, A.: Biochemistry of Parkinson’s disease. Excerpta Medica Int. Congr. Ser. 38, 152–153 (1961).Google Scholar
- Barbeau, A.: The clinical physiology of side-effects in long-term L-DOPA therapy. In: Advances in Neurology, Vol. 5 (McDowell, F. FL., Barbeau, A., eds.), pp. 347–365. New York: Raven Press. 1979.Google Scholar
- Barbeau, A.: Neurological and Psychiatric side-effects of L-DOPA. In: Int. Encyclop. of Pharmacol. and Therap., Sect. 25 (Hornykiewicz, O., ed.), Vol. 1, pp. 475–494 (1976).Google Scholar
- Earnest, M. P., Heaton, R. K., Wilkinson, W. E., Manke, W. F.: Cortical atrophy, ventricular enlargement and intellectual impairment in the aged. Neurology (Minneap.) 29, 1138–1143 (1979).Google Scholar
- Hakim, A. M., Mathieson, G.: Dementia in Parkinson’s disease: a neuropathologic study. Neurology (Minneap.) 29, 1209–1214 (1979).Google Scholar
- Samoroyski, T.: Central neurotransmitter substances and aging: a review. J. Am. Geriat. Soc. 25, 337–348 (1977).Google Scholar